TRIDENT LIFELINE
Back to Cashflow Statement
|
TRIDENT LIFELINE Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-4.31 Cr | ₹-7.13 Cr | ₹14 Cr | ₹0.14 Cr |
What is the latest Net Cash Inflow / Outflow ratio of TRIDENT LIFELINE ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-4.31 Cr |
| Mar2024 | ₹-7.13 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹0.14 Cr |
How is Net Cash Inflow / Outflow of TRIDENT LIFELINE Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-4.31 Cr | Negative | |
| Mar2024 | ₹-7.13 Cr | Negative | |
| Mar2023 | ₹14 Cr | 9,474.65 | |
| Mar2022 | ₹0.14 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹293.3 Cr | 0.1% | -11.7% | -13.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,782.0 Cr | -2.5% | 4.7% | 7.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,125.0 Cr | -2.1% | -0.2% | 7.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,252.0 Cr | -3.4% | 0.7% | 39.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,025.0 Cr | -1.9% | 2% | 16.1% | Stock Analytics | |
| CIPLA | ₹102,443.0 Cr | -4.3% | -6.5% | -11.9% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 0.1% |
-11.7% |
-13.5% |
| SENSEX | -0.2% |
-7.2% |
3.5% |
You may also like the below Video Courses